PALVELLA THERAPEUTICS, INC. Altman Z-Score
PVLA / Health Care|Modified Z-Score (book value) based on FY2024 data
PALVELLA THERAPEUTICS, INC.'s Altman Z-Score of 1.15 places the company in the "distress zone" used by the Altman model (below 1.23) for FY2024. Z-Score is calculated from 5 financial ratios derived from PALVELLA THERAPEUTICS, INC.'s SEC 10-K filing, evaluated in the context of the Health Care sector.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Distress Zone (< 1.23)
The score is below the 1.23 boundary used in the Altman model.
The Altman Z-Score uses 5 financial ratios. Learn more
Profit margin ranks in the top 10% of Health Care companies
Components: book value of equity, working capital, retained earnings, EBIT, and revenue-to-assets — all derived from SEC FY2024 10-K filings.
5-Factor Decomposition
Working Capital / Total Assets
- Ratio
- 0.864
- Weight
- 0.717
- Contribution
- 0.619
Retained Earnings / Total Assets
- Ratio
- -
- Weight
- 0.847
- Contribution
- -
EBIT / Total Assets
- Ratio
- -0.160
- Weight
- 3.107
- Contribution
- -0.496
Book Equity / Total Liabilities
- Ratio
- 2.443
- Weight
- 0.420
- Contribution
- 1.026
Revenue / Total Assets
- Ratio
- -
- Weight
- 0.998
- Contribution
- -
| Component | Ratio | Weight | Contribution |
|---|---|---|---|
| Working Capital / Total Assets | 0.864 | 0.717 | 0.619 |
| Retained Earnings / Total Assets | - | 0.847 | - |
| EBIT / Total Assets | -0.160 | 3.107 | -0.496 |
| Book Equity / Total Liabilities | 2.443 | 0.420 | 1.026 |
| Revenue / Total Assets | - | 0.998 | - |
| Total Z-Score | 1.15 | ||
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026
Z-Score Zones
Safe Zone - score above the 2.9 boundary used in the Altman model.
Grey Zone - score between the 1.23 and 2.9 boundaries used in the Altman model.
Distress Zone - score below the 1.23 boundary used in the Altman model.